(rac)-N-{4-[(6-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-5-yl)carbonyl]phenyl}-2-methylbenzamide

ID: ALA3416767

PubChem CID: 118734334

Max Phase: Preclinical

Molecular Formula: C25H24N2O2S

Molecular Weight: 416.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1

Standard InChI:  InChI=1S/C25H24N2O2S/c1-17-7-3-4-9-21(17)24(28)26-20-13-11-19(12-14-20)25(29)27-15-6-16-30-22-10-5-8-18(2)23(22)27/h3-5,7-14H,6,15-16H2,1-2H3,(H,26,28)

Standard InChI Key:  LQCRQEJXMNDRFQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -1.4884   -1.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4637    6.8428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5483    5.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7442   -1.6517    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9829    3.2321    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6064    4.0689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1195    4.2676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8315   -0.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2904    9.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9505    6.6441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5218    5.2572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1007    9.3787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4432   11.9585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5481   12.9878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8315    0.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9404    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2507    1.3976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6326   11.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2069    3.0761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7805    1.6880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6062   11.4023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0348   12.7892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2039   10.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6908   10.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8640    7.8349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4884    1.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2325   -1.4158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5141    2.7244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 18 13  1  0
 20 19  1  0
 29  1  2  0
 25 24  1  0
 28 16  1  0
  9 24  1  0
  8 15  2  0
  3  7  1  0
 23 29  1  0
 21 25  2  0
  4 28  1  0
  1  8  1  0
  6 11  1  0
  7  6  2  0
 15 27  1  0
 11 10  2  0
 23 20  1  0
 19  5  2  0
 18 14  1  0
 20 17  1  0
 22 21  1  0
 24 18  2  0
  2  3  2  0
 10 26  1  0
 17 16  1  0
  9 12  2  0
 27 23  2  0
 26  9  1  0
 29  4  1  0
 14 22  2  0
 19  7  1  0
 10  2  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3416767

    ---

Associated Targets(Human)

AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.55Molecular Weight (Monoisotopic): 416.1558AlogP: 5.70#Rotatable Bonds: 3
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.46CX LogD: 5.46
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.60Np Likeness Score: -1.68

References

1. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H..  (2015)  N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring.,  58  (7): [PMID:25774991] [10.1021/acs.jmedchem.5b00289]
2. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H..  (2015)  N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring.,  58  (7): [PMID:25774991] [10.1021/acs.jmedchem.5b00289]
3. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H..  (2015)  N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring.,  58  (7): [PMID:25774991] [10.1021/acs.jmedchem.5b00289]
4. Glunz PW..  (2018)  Recent encounters with atropisomerism in drug discovery.,  28  (2.0): [PMID:29223590] [10.1016/j.bmcl.2017.11.050]

Source